https://www.abc.net.au/news/health/2021-04-26/university-que...
Blood clot risk is much higher the younger you are[1]. It would have been far better to continue using AstraZeneca, but limit it to a certain age and older.
[1] For example, 1.1 of the specific clots per 100 000 vaccinations of people in their 20s, falling to 0.2 per 100 000 in their 60s. https://wintoncentre.maths.cam.ac.uk/news/communicating-pote...
Until recently it was the only vaccine available for over 60s even.
Also FWIW. The risk of blood clots seems to be significantly higher in women than men. I think they should have focused on giving AZ to men and Pfizer to younger women.
For a while though some states were giving Pfizer to men in their 40s and 50s working from home, while recommending young women go and get dosed with AZ.
In a different timeline if the AZ vaccine hadn’t been associated with rare blood clotting, if Pfizer/Moderna hasn’t been able to scale manufacturing as well that strategy would be looking very good.
It’s interesting to think that Canada and other nations that instead depended on international supply chains ultimately did much better though.